201 related articles for article (PubMed ID: 32174022)
41. Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways.
Lien LM; Lin KH; Huang LT; Tseng MF; Chiu HC; Chen RJ; Lu WJ
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704925
[TBL] [Abstract][Full Text] [Related]
42. Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase.
Liu Y; Hu M; Luo D; Yue M; Wang S; Chen X; Zhou Y; Wang Y; Cai Y; Hu X; Ke Y; Yang Z; Hu H
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2075-2086. PubMed ID: 28882875
[TBL] [Abstract][Full Text] [Related]
43. Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice.
Qin Q; Mehta H; Yen K; Navarrete G; Brandhorst S; Wan J; Delrio S; Zhang X; Lerman LO; Cohen P; Lerman A
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1127-H1136. PubMed ID: 30004252
[TBL] [Abstract][Full Text] [Related]
44. Kinesin-1 Is a New Actor Involved in Platelet Secretion and Thrombus Stability.
Adam F; Kauskot A; Kurowska M; Goudin N; Munoz I; Bordet JC; Huang JD; Bryckaert M; Fischer A; Borgel D; de Saint Basile G; Christophe OD; Ménasché G
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1037-1051. PubMed ID: 29519941
[TBL] [Abstract][Full Text] [Related]
45. Morin hydrate inhibits platelet activation and clot retraction by regulating integrin α
Nam GS; Lee KS; Nam KS
Eur J Pharmacol; 2019 Dec; 865():172734. PubMed ID: 31614139
[TBL] [Abstract][Full Text] [Related]
46. HDAC6 controls the kinetics of platelet activation.
Sadoul K; Wang J; Diagouraga B; Vitte AL; Buchou T; Rossini T; Polack B; Xi X; Matthias P; Khochbin S
Blood; 2012 Nov; 120(20):4215-8. PubMed ID: 22955928
[TBL] [Abstract][Full Text] [Related]
47. Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2.
Konopatskaya O; Matthews SA; Harper MT; Gilio K; Cosemans JM; Williams CM; Navarro MN; Carter DA; Heemskerk JW; Leitges M; Cantrell D; Poole AW
Blood; 2011 Jul; 118(2):416-24. PubMed ID: 21527521
[TBL] [Abstract][Full Text] [Related]
48. Role of heterotrimeric G proteins in platelet activation and clot formation in platelets treated with integrin αIIbβ3 inhibitor.
Budnik I; Shenkman B; Hauschner H; Zilinsky I; Savion N
Platelets; 2018 May; 29(3):265-269. PubMed ID: 28406726
[TBL] [Abstract][Full Text] [Related]
49. Sunitinib uptake inhibits platelet function in cancer patients.
Sabrkhany S; Griffioen AW; Pineda S; Sanders L; Mattheij N; van Geffen JP; Aarts MJ; Heemskerk JW; Oude Egbrink MG; Kuijpers MJ
Eur J Cancer; 2016 Oct; 66():47-54. PubMed ID: 27525572
[TBL] [Abstract][Full Text] [Related]
50. Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis.
Holly SP; Gera N; Wang P; Wilson A; Guan Z; Lin L; Cooley B; Alfar HR; Patil RG; Piatt R; Leisner TM; Bergmeier W; Majumder R; Parise LV
Blood Adv; 2019 Nov; 3(22):3818-3828. PubMed ID: 31770438
[TBL] [Abstract][Full Text] [Related]
51. Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets.
Hsia CW; Lin KC; Lee TY; Hsia CH; Chou DS; Jayakumar T; Velusamy M; Chang CC; Sheu JR
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163690
[TBL] [Abstract][Full Text] [Related]
52. Suppression of Human Platelet Activation via Integrin α
Hsia CW; Tsai CL; Sheu JR; Lu WJ; Hsia CH; Velusamy M; Jayakumar T; Li JY
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717348
[TBL] [Abstract][Full Text] [Related]
53. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
54. Doxepin inhibits GPVI-dependent platelet Ca
Geue S; Walker-Allgaier B; Eißler D; Tegtmeyer R; Schaub M; Lang F; Gawaz M; Borst O; Münzer P
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C765-C774. PubMed ID: 28404545
[TBL] [Abstract][Full Text] [Related]
55. Platelet biology and functions: new concepts and clinical perspectives.
van der Meijden PEJ; Heemskerk JWM
Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
[TBL] [Abstract][Full Text] [Related]
56. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
57. Dual inhibition of PI3K and mTOR by VS-5584 suppresses thrombus formation.
Später T; Müller I; Eichler H; Menger MD; Laschke MW; Ampofo E
Platelets; 2018 May; 29(3):277-287. PubMed ID: 28503993
[TBL] [Abstract][Full Text] [Related]
58. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
59. Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation.
Wang X; Wei G; Ding Y; Gui X; Tong H; Xu X; Zhang S; Sun Z; Ju W; Li Y; Yao R; Wu Q; Lu Z; Fu C; Li Z; Zhang S; Gardiner EE; Andrews RK; Hu H; Zeng L; Xu K; Qiao J
Blood; 2022 Sep; 140(9):1038-1051. PubMed ID: 35767715
[TBL] [Abstract][Full Text] [Related]
60. EMILIN2 regulates platelet activation, thrombus formation, and clot retraction.
Huang M; Sannaningaiah D; Zhao N; Gong Y; Grondolsky J; Hoover-Plow J
PLoS One; 2015; 10(2):e0115284. PubMed ID: 25658937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
